On May 22, 2025, WeightWatchers announced a strategic partnership with CheqUp, a leading UK provider of GLP-1 based weight loss services. This collaboration aims to combine the offerings of both organizations to benefit patients seeking sustainable weight loss through GLP-1 medication and behavioral support.
The partnership extends WeightWatchers' integrated care model into the UK market, offering CheqUp members access to WeightWatchers' GLP-1 Companion Programme at no additional cost. This program provides structured, science-backed, and supportive behavioral tools for those using GLP-1 medications.
Data from the U.S. indicates that members on obesity medications who also participate in WeightWatchers' nutritional and behavioral lifestyle program lose 11% more weight on average than those using medication alone. This partnership addresses the growing demand for GLP-1 medications in the UK by offering a holistic model of care, leveraging WeightWatchers' proven programs and global community.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.